Plain-English translation of NCT06339190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether a blood test measuring a protein called neurofilament light chain, combined with voice analysis and genetic testing, can help doctors diagnose dementia more quickly and accurately. Currently, there is no single reliable test for dementia, which delays diagnosis and causes stress for patients and families. This study aims to develop simpler, more accessible ways to identify dementia in its early stages.
Many people with early dementia symptoms are not caught by standard memory tests, especially if English is not their first language or they come from diverse educational backgrounds. New therapies for dementia are becoming available, but without better diagnostic tools, many people go undiagnosed for years. This research aims to create affordable, accessible tests that can help people get diagnosed and treated sooner.
You likely qualify if…
You likely don't qualify if…
You would visit an Eastern Health clinic where you would provide a blood sample, give a voice recording, and potentially provide a saliva sample for genetic testing. The researchers will then analyze these samples along with information about your cognitive concerns. The study is designed to be straightforward and fit into your regular healthcare visits, with the goal of helping develop better ways to diagnose dementia.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Australia